An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria | MicrobiomeTrials← Back to trialsNCT06927999
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-07-09Est. Completion: 2027-06
Enrollment target: 42 participants Locations- Endeavor Health Clinical Trials Center, Glenview, Illinois, United States
- Bernstein Clinical Research Center, LLC, Cincinnati, Ohio, United States
- Institute of Allergology IFA Charité - Campus Benjamin Franklin | Hindenburgdamm 30, Berlin, Germany
Other microbiome trials you might be interested in
Chronic Urticaria
Urticaria is a common skin disorder and 15-25% of people experience at least one attack of urticaria during their lifeti…
Shatin, Hong KongCompleted Apr 7, 2023
Chronic Inducible UrticariaChronic Spontaneous Urticaria
This is a 2-part, proof-of-concept study to be conducted globally, designed to evaluate the safety, tolerability, clinic…
Birmingham, United StatesEst. completion Dec 31, 2026